German cannabis exports surged 74% year-over-year, driving net income to $7.2 million.

Collection rate headwinds and delayed cost cuts weighed on Q2 results.

Data protection gains offset by pricing pressure in endpoint markets.

Patent setback forces guidance withdrawal as acute care revenue surges 44% year over year.

Gaming revenue beat guidance on expansion packs, but Q3 outlook signals sharp slowdown ahead.

Net debt fell 45.5% as cash flow hit a six-year high.

AI technologies now contribute 20% of licensing revenue, marking a step-function inflection.

Revenue fell 11.9% as contract losses mounted, but management targets 10% margins ahead.

Perion One spend surged 15% as management narrowed full-year guidance.